FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:364-367 January 31, 2002 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Joly, P. PubMed Citation

Until now, systemic immunosuppressive agents, particularly oral corticosteroids, have been the standard treatment for bullous pemphigoid, which accounts for about 75 percent of cases of autoimmune blistering skin disease.^1,2,3 Nearly two thirds of cases occur in persons 80 years of age or older.^2,3 In France, whose population is one fifth that of the United States, about 500 new cases of bullous pemphigoid occur each year.^2,3

Bullous pemphigoid can usually be distinguished from other blistering skin diseases on the basis of at least three of four criteria: the absence of atrophic scars, the absence of mucosal involvement, the absence of involvement . . . [Full Text of this Article]

References

Related Letters:

Oral and Topical Corticosteroids in Bullous Pemphigoid
Korman N. J., Ardern-Jones M. R., Venning V. A., Wojnarowska F., Bystryn J.-C., Wainwright B. D., Shupack J. L., Spigel G. T., Joly P., Roujeau J.-C., Benichou J., Stern R. S.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:143-145, Jul 11, 2002. Correspondence

This article has been cited by other articles:

• Joly, P., Benichou, J., Lok, C., Hellot, M. F., Saiag, P., Tancrede-Bohin, E., Sassolas, B., Labeille, B., Doutre, M. S., Gorin, I., Pauwels, C., Chosidow, O., Caux, F., Esteve, E., Dutronc, Y., Sigal, M., Prost, C., Maillard, H., Guillaume, J. C., Roujeau, J. C. (2005). Prediction of Survival for Patients With Bullous Pemphigoid: A Prospective Study. Arch Dermatol 141: 691-698 [Abstract] [Full Text]  
• Korman, N. J., Ardern-Jones, M. R., Venning, V. A., Wojnarowska, F., Bystryn, J.-C., Wainwright, B. D., Shupack, J. L., Spigel, G. T., Joly, P., Roujeau, J.-C., Benichou, J., Stern, R. S. (2002). Oral and Topical Corticosteroids in Bullous Pemphigoid. NEJM 347: 143-145 [Full Text]  
• (2002). Is Local Therapy for Bullous Pemphigoid Really Lower-Dose Systemic Therapy?. Journal Watch Dermatology 2002: 3-3 [Full Text]